Zobrazeno 1 - 10
of 45
pro vyhledávání: '"G. Tormans"'
Publikováno v:
The European Journal of Public Health. 5:245-252
Hepatitis B (HBV) is the most important occupational hazard facing workers in the hearth care and related environments. It is a serious, but underestimated, occupational hazard among such personnel, who are at a 2 to 10 times greater risk of infectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f51aa8cbdab90c66c3fa4f6a313330b
https://doi.org/10.1093/eurpub/5.4.245
https://doi.org/10.1093/eurpub/5.4.245
Publikováno v:
Social science and medicine (1982)
The study examines the cost-effectiveness of screening pregnant women in Belgium for the presence of hepatitis B virus (HBV) and of vaccinating the newborns if necessary. The alternative strategy considered is 'doing nothing'. The rate of carriership
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9c9c94bd6e6e6ada931aab8a52f6aa5
https://doi.org/10.1016/0277-9536(93)90453-b
https://doi.org/10.1016/0277-9536(93)90453-b
Publikováno v:
Vaccine, 10(Suppl. 1), S88-S92. Elsevier
Vaccine
Vaccine
The advent of new vaccines and the changing epidemiology of hepatitis A call for an update of the economic evaluation of costs and benefits associated with the various alternative preventative strategies. A decision-tree-based model has been develope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ead824a7f2dbca577e5a9f0d69f35034
https://doi.org/10.1016/0264-410X(92)90554-W
https://doi.org/10.1016/0264-410X(92)90554-W
Publikováno v:
Vaccine
An economic evaluation was performed of universal acellular pertussis vaccination in Italy, where until recently the overall coverage of pertussis vaccination was estimated at 50%. Over the last two years coverage seems to have increased rapidly. By
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26fe57449f0c9ed887f743959560803f
https://hdl.handle.net/10067/248430151162165141
https://hdl.handle.net/10067/248430151162165141
Publikováno v:
Military medicine. 163(8)
We analyzed the cost-effectiveness of hepatitis A vaccination regimens using a mathematical simulation model. Passive immunization and two active vaccination strategies (with and without prior screening) were compared with "doing nothing." Hepatitis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c6d211c5e281aaabf580fbbf5fc3482a
https://pubmed.ncbi.nlm.nih.gov/9715622
https://pubmed.ncbi.nlm.nih.gov/9715622
Publikováno v:
European Journal of Pediatrics, 157, 395-401. Springer-Verlag
European journal of pediatrics
European journal of pediatrics
Acellular pertussis vaccines are less reactogenic than whole cell pertussis vaccines, but they are also more expensive. Based on simulation models, we compared the costs and effects of three alternative pertussis vaccination strategies in German chil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4db1e9a731fe6b91e85c69c6d6501ebe
https://pure.eur.nl/en/publications/d20e2c20-6f6e-4ddc-b379-fc68cfa686c4
https://pure.eur.nl/en/publications/d20e2c20-6f6e-4ddc-b379-fc68cfa686c4
Autor:
G. Tormans, Philippe Beutels, A. H. Buma, A. Leentvaar-Kuijpers, P. Van Damme, E. van Doorslaer
Publikováno v:
Military Medicine, 163(8), 564-567. Association of Military Surgeons of the US
EUR Research Portal
Military medicine
EUR Research Portal
Military medicine
We analyzed the cost-effectiveness of hepatitis A vaccination regimens using a mathematical simulation model. Passive immunization and two active vaccination strategies (with and without prior screening) were compared with "doing nothing." Hepatitis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66465e6366f308b944c3c7c61f842962
https://pure.eur.nl/en/publications/f5a37171-e364-48c2-93ae-f6da9acb889f
https://pure.eur.nl/en/publications/f5a37171-e364-48c2-93ae-f6da9acb889f
Publikováno v:
BMJ, 310(6976). BMJ Publishing Group
EDITOR,—We have performed economic evaluations of prophylaxis against hepatitis A in travellers, and two of R H Behrens and J A Roberts's main conclusions1 are in line with our findings2 3—namely, that hepatitis A vaccination is not cost saving f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d2d17928bfc50379cfc45bc5fe450e0
https://pure.eur.nl/en/publications/f400d888-5e12-42b5-ae21-8f351a2b7ca8
https://pure.eur.nl/en/publications/f400d888-5e12-42b5-ae21-8f351a2b7ca8
Publikováno v:
Pharmacoeconomics
The hepatitis A virus (HAV) is the most widespread of all the viruses that cause hepatitis. being prevalent wherever standards of hygiene and sanitation are poor. By far the mosl common route of transmission is through the ingestion of food or water
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::260e87488d44cd4914f3b6c2b36ccca9
https://hdl.handle.net/10067/128010151162165141
https://hdl.handle.net/10067/128010151162165141
Publikováno v:
EUR Research Portal
Vaccine
Vaccine, 13(Suppl.1), S54-S57. Elsevier
Vaccine
Vaccine, 13(Suppl.1), S54-S57. Elsevier
The World Health Organization (WHO) estimates that about 350 million people in the world are carriers of the hepatitis B virus (HBV), 60 million of whom may die from liver cancer and about 45 million from cirrhosis. In the WHO European Region, which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57f9dad438a5572cd93edf89035de89d
https://pubmed.ncbi.nlm.nih.gov/7571833
https://pubmed.ncbi.nlm.nih.gov/7571833